ArticleScientific reports2022

First-in-class trispecific VHH-Fc based antibody with potent prophylactic and therapeutic efficacy against SARS-CoV-2 and variants.

Allison Titong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.